News und Analysen
Westwater Resources Announces First Quarter Business Updates and Date of Investor Call
Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite development company (“Westwater” or the “Company”), is pleased to announce its results for
EQS-News: Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2025 and New Supervisory Board
EQS-News: Ucore provided with USD 18.4 million by U.S. DoD for commercialization of its rare earth technology!
Custodian Property Income REIT plc: Disposal of Properties at or above book value
EQS-News: Deutsche Konsum REIT reports stable rental performance in the first half of 2024/2025 with a focus on refinancing
EQS-News: Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025
EQS-Adhoc: Bitcoin Group SE: Forecast for the 2024 financial year significantly exceeded
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: Urban Logistics REIT plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
CI Financial Reports Financial Results for the First Quarter of 2025
CI Financial Corp. (“CI”) (TSX: CIX) today released financial results for the quarter ended March 31, 2025.
Financial highlights
First quarter net loss attributable to shareholders was $8.5
EQS-News: clearvise AG invests in 16.75 MWp agri-PV project in Bavaria
Median Technologies submits U.S. application for 510(k) clearance of eyonis® LCS
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software
EQS-News: Cost-cutting programme already initiated in 2024 with first results in Q1/2025 – Restructuring proceeding according to plan and internationalisation 2.0 with positive impact
Mannatech Reports Financial Results for First Quarter 2025
Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for
GenSight Biologics Announces Approval of All Resolutions Supported by the Board of Directors at the Combined General Meeting of May 13, 2025
Regulatory News:
The Combined General Meeting of shareholders of GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and
Correction of a release from 12.05.2025 17:37 CET/CEST - Revenue for Q1 2025: 19.7 M€, up +36.5%
Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss
Molten Ventures Plc: Full year results presentation
EQS-News: Medios starts 2025 financial year successfully with significant increase in earnings
EQS-News: Daldrup & Söhne AG receives drilling contract for geothermal doublet in Prenzlau, Germany